InvestSMART

Tissue Repair Ltd (ASX:TRP)

ALERT: Price-sensitive ASX Announcement for TRP
Current share price for TRP : $0.110 -0.13 (-54.17%)+
Announcement
Release
31 Jul 2025 11:57AM
Price at Release
$0.240
Full Release
download
Summary
Tissue Repair Ltd (TRP) released its Quarterly Activities Report and Appendix 4C Cash Flow Report for the quarter ending 31 March 2024. The report details the company's progress in clinical trials, including completion of patient enrollment for the Phase III SURF1 study of TR-987 in chronic wounds, progress in regulatory interactions, and preparations for data readouts. Financially, TRP reported an operating cash outflow mainly driven by research and development expenses, and stated that it has sufficient cash reserves to fund planned activities. The report also discusses ongoing business development initiatives, forward-looking statements regarding commercial strategy, and compliance with ASX listing requirements.
Key Points
  • Completed patient enrollment for Phase III SURF1 clinical trial of TR-987 for chronic wounds
  • Ongoing regulatory interactions with relevant authorities for approvals and guidance
  • Preparation for top-line data readout from SURF1 study expected in Q2 2024
  • Operating cash outflows primarily related to research and development activities
  • TRP maintains adequate cash reserves to support planned clinical and operational activities
  • Business development efforts continue, including potential partnerships and strategic collaborations
  • Declared compliance with ASX Listing Rule 4.7C regarding use of funds
  • Forward-looking statements made concerning future milestones and commercialization plans
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.